1. Home
  2. OPY vs VALN Comparison

OPY vs VALN Comparison

Compare OPY & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPY
  • VALN
  • Stock Information
  • Founded
  • OPY 1881
  • VALN 2012
  • Country
  • OPY United States
  • VALN France
  • Employees
  • OPY N/A
  • VALN N/A
  • Industry
  • OPY Investment Bankers/Brokers/Service
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OPY Finance
  • VALN Health Care
  • Exchange
  • OPY Nasdaq
  • VALN Nasdaq
  • Market Cap
  • OPY 599.0M
  • VALN 510.7M
  • IPO Year
  • OPY N/A
  • VALN 2021
  • Fundamental
  • Price
  • OPY $58.57
  • VALN $7.01
  • Analyst Decision
  • OPY
  • VALN Strong Buy
  • Analyst Count
  • OPY 0
  • VALN 2
  • Target Price
  • OPY N/A
  • VALN $16.00
  • AVG Volume (30 Days)
  • OPY 40.7K
  • VALN 139.5K
  • Earning Date
  • OPY 04-25-2025
  • VALN 05-06-2025
  • Dividend Yield
  • OPY 1.23%
  • VALN N/A
  • EPS Growth
  • OPY 84.56
  • VALN N/A
  • EPS
  • OPY 6.74
  • VALN N/A
  • Revenue
  • OPY $1,358,354,000.00
  • VALN $175,564,758.00
  • Revenue This Year
  • OPY N/A
  • VALN $19.17
  • Revenue Next Year
  • OPY N/A
  • VALN $26.31
  • P/E Ratio
  • OPY $8.77
  • VALN N/A
  • Revenue Growth
  • OPY 12.80
  • VALN 10.32
  • 52 Week Low
  • OPY $38.51
  • VALN $3.62
  • 52 Week High
  • OPY $73.12
  • VALN $9.50
  • Technical
  • Relative Strength Index (RSI)
  • OPY 52.93
  • VALN 53.54
  • Support Level
  • OPY $54.98
  • VALN $6.77
  • Resistance Level
  • OPY $59.27
  • VALN $7.05
  • Average True Range (ATR)
  • OPY 2.65
  • VALN 0.43
  • MACD
  • OPY 0.69
  • VALN 0.05
  • Stochastic Oscillator
  • OPY 85.05
  • VALN 79.72

About OPY Oppenheimer Holdings Inc. (DE)

Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: